ARBOR BIOTECHNOLOGIES Trademark

Trademark Overview


On Friday, April 15, 2022, a trademark application was filed for ARBOR BIOTECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the ARBOR BIOTECHNOLOGIES trademark a serial number of 97365239. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Wednesday, February 28, 2024. This trademark is owned by Arbor Biotechnologies, Inc.. The ARBOR BIOTECHNOLOGIES trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others

Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use

Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy
arbor biotechnologies

General Information


Serial Number97365239
Word MarkARBOR BIOTECHNOLOGIES
Filing DateFriday, April 15, 2022
Status760 - EX PARTE APPEAL PENDING
Status DateWednesday, February 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesManufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others
Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use
NOT AVAILABLE"BIOTECHNOLOGIES"
Goods and ServicesPharmaceutical research and development; research and development in the fields of gene therapy and cell therapy

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, August 4, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 20, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArbor Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Wednesday, April 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 19, 2022NEW APPLICATION ENTERED
Thursday, February 2, 2023ASSIGNED TO EXAMINER
Friday, February 3, 2023NON-FINAL ACTION WRITTEN
Friday, February 3, 2023NON-FINAL ACTION E-MAILED
Friday, February 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 2, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 2, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2023FINAL REFUSAL WRITTEN
Thursday, August 31, 2023FINAL REFUSAL E-MAILED
Thursday, August 31, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 27, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, November 27, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, February 28, 2024EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, February 28, 2024EX PARTE APPEAL-INSTITUTED
Monday, November 4, 2024ASSIGNED TO EXAMINER
Monday, November 4, 2024ASSIGNED TO EXAMINER